Pitfalls of prioritizing cost-effectiveness in the assessment of medical innovation: A comment on Wallis and Detsky guest editorial
Can Urol Assoc J
.
2018 Mar;12(3):E163-E165.
doi: 10.5489/cuaj.5119.
Epub 2017 Dec 22.
Authors
Mike Paulden
1
,
Christopher Mccabe
2
Affiliations
1
School of Public Health; University of Alberta, Edmonton, AB, Canada.
2
Institute for Health Economics; University of Alberta, Edmonton, AB, Canada.
PMID:
29319484
PMCID:
PMC5869043
DOI:
10.5489/cuaj.5119
No abstract available